Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.96), versus ($0.68) reported last year. Revenue for the quarter came in at $15.8 million, versus $32.4 million reported last year.

For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.